Lupin and Huons Ink Agreement for Commercialization of Cyclosporine Ophthalmic Nanoemulsion
Lupin and Huons ink license and supply agreement for commercialization of cyclosporine ophthalmic nanoemulsion in Mexico
Overview
Lupin Limited (Lupin) announced that it has signed a license and supply agreement with Huons Co. Ltd for the registration and marketing of cyclosporine ophthalmic nanoemulsion, 0.4mL single-use vial, in Mexico.
About Cyclosporine Ophthalmic Nanoemulsion
Cyclosporine ophthalmic nanoemulsion is a preservative-free nanoemulsion that has been approved in South Korea, Peru and several countries in the Middle East for treatment of dry eye syndrome and healing corneal ulcers.
Thanks to its unique nanoparticle technology, it can relieve symptoms faster by increasing the tear production in patients with suppressed tear formation due to keratoconjunctivitis sicca-related ocular inflammatory disease.
Statement from Lupin on the Partnership
“We are delighted to partner with Huons to introduce cyclosporine ophthalmic nanoemulsion in Mexico and offer a novel technology that provides significant benefits to our patients suffering from dry eye. With this addition to our ophthalmology portfolio, we continue to strengthen our commitment to provide better healthcare and eyecare solutions to our patients, improving patient quality of life and vision,” said Dr. Fabrice Egros, president – corporate development and growth markets, Lupin.
From the Senior Director: Huons
Yohun Aum, senior director – head of global business division, Huons said, “Introducing our cyclosporine ophthalmic nanoemulsion in Mexico is a significant milestone for Huons. We look forward to strengthening our partnership by supplying high quality products for Mexico.”
About Lupin
Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai, India.
The company develops and commercializes a wide range of branded and generic formulations, biotechnology products, and APIs in over 100 markets in the US, India, South Africa, and across the Asia Pacific (APAC), Latin America (LATAM), Europe, and Middle East regions.
About Huons
Huons, a subsidiary of Huons Global, is the leading pharmaceutical company in Korea with a history of 60 years of manufacturing and supplying various prescription drugs - from eye drops, injections to oral solids.